Aikaterini Dedeilia, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 5 | 2024 | 5702 | 0.670 |
Why?
|
Happiness | 1 | 2020 | 170 | 0.650 |
Why?
|
Skin Neoplasms | 5 | 2024 | 5859 | 0.630 |
Why?
|
Goals | 1 | 2020 | 717 | 0.490 |
Why?
|
General Surgery | 3 | 2020 | 1720 | 0.460 |
Why?
|
Internal Medicine | 1 | 2020 | 1064 | 0.410 |
Why?
|
Students, Medical | 3 | 2020 | 1965 | 0.360 |
Why?
|
Education, Medical | 1 | 2020 | 1746 | 0.300 |
Why?
|
Pandemics | 2 | 2023 | 8736 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3112 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3234 | 0.200 |
Why?
|
Asia | 1 | 2023 | 629 | 0.190 |
Why?
|
Thematic Apperception Test | 1 | 2021 | 40 | 0.180 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11217 | 0.180 |
Why?
|
Holistic Health | 1 | 2020 | 47 | 0.170 |
Why?
|
Protective Devices | 1 | 2020 | 72 | 0.170 |
Why?
|
Telomerase | 1 | 2024 | 751 | 0.160 |
Why?
|
Herpesvirus 1, Human | 1 | 2024 | 743 | 0.160 |
Why?
|
Oncolytic Virotherapy | 1 | 2024 | 520 | 0.160 |
Why?
|
Sarcopenia | 1 | 2023 | 378 | 0.150 |
Why?
|
Education, Distance | 1 | 2020 | 260 | 0.130 |
Why?
|
Educational Measurement | 2 | 2021 | 1259 | 0.130 |
Why?
|
Curriculum | 2 | 2020 | 3786 | 0.130 |
Why?
|
Specialties, Surgical | 1 | 2021 | 391 | 0.130 |
Why?
|
Biological Products | 1 | 2024 | 948 | 0.120 |
Why?
|
Clinical Competence | 2 | 2021 | 4859 | 0.120 |
Why?
|
Workload | 1 | 2020 | 849 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2023 | 1173 | 0.100 |
Why?
|
Prognosis | 5 | 2024 | 29963 | 0.100 |
Why?
|
Survival Rate | 2 | 2024 | 12823 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1759 | 0.100 |
Why?
|
Teaching | 1 | 2020 | 1172 | 0.100 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2420 | 0.090 |
Why?
|
Education, Medical, Undergraduate | 1 | 2020 | 1087 | 0.090 |
Why?
|
Learning | 1 | 2020 | 1754 | 0.090 |
Why?
|
Health Personnel | 1 | 2023 | 3387 | 0.080 |
Why?
|
Humans | 15 | 2024 | 767040 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5446 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9410 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.050 |
Why?
|
Depression | 1 | 2021 | 8234 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2024 | 81659 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3944 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2024 | 726 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5947 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13485 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2021 | 1623 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 1105 | 0.040 |
Why?
|
Aged | 3 | 2024 | 171319 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2127 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1761 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22350 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3432 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2058 | 0.030 |
Why?
|
Aorta | 1 | 2021 | 2045 | 0.030 |
Why?
|
Data Collection | 1 | 2021 | 3321 | 0.020 |
Why?
|
Male | 3 | 2024 | 364203 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3584 | 0.020 |
Why?
|
Female | 3 | 2024 | 396660 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4648 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30211 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12536 | 0.020 |
Why?
|
Patient Selection | 1 | 2021 | 4256 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6260 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54886 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13646 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4670 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5101 | 0.020 |
Why?
|
United States | 2 | 2024 | 72971 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8729 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10869 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39317 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59548 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41718 | 0.010 |
Why?
|
Adult | 2 | 2024 | 223317 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 65295 | 0.010 |
Why?
|
Middle Aged | 1 | 2024 | 223233 | 0.010 |
Why?
|